American Mayo Clinic Visits Norway
Innovation Norway and DNV (Det Norske Veritas) recently hosted representatives from the Mayo Clinic in the United States for three consecutive days, aiming to foster a long-term collaboration.
Mayo Clinic is the largest non-profit hospital chain in the world, with clinics and research activities in several states across the USA, as well as in London. The hospital was established 150 years ago by brothers Will and Charlie Mayo, and each year, over one million patients from the USA and 140 other countries receive treatment at the clinic. Read more here.
Mayo Clinic Innovation Exchange works to bring together entrepreneurs, startups, and industry experts to bring groundbreaking innovations to market, benefiting patients worldwide. Representatives from both the Innovation Exchange and Mayo Clinic clinicians hope their visit to Norway will help identify common areas of interest and potential for research and development collaboration.
Innovation Norway is confident that Norway has much to offer in such collaborations: “We have a competitive healthcare industry with excellent research environments and unique health data. The government is investing heavily in world-class infrastructure, and health is a prioritized export sector. Our unified healthcare system and highly digitalized society enable state-of-the-art digital health solutions and clinical trials. Norway offers a strong ecosystem of clusters and incubators, and a pool of promising early-stage companies. Environmentally friendly production, with renewable energy, circular processes, and automation, makes sustainable health solutions possible,” they write on their global outreach platform, Business Norway.
As part of the three-day visit, Innovation Norway organized a reception at DNV’s premises on Wednesday evening, titled “Connect with the Future of Healthcare!” Approximately 100 representatives from the healthcare and health industry were invited. Among the attendees were Signe Fretland and Ingrid Bånerud from the NorTrials coordinating unit, and Åslaug Helland and Peder Langeland Myhre from NorTrials Cancer and NorTrials Cardiovascular, respectively.
Jenny Kung, Vice Chair at Mayo Clinic Innovation Exchange, shared some insights into their motivation for coming to Norway. “We are here to better understand how we can be part of the incredible health innovation community and ecosystem here. We are working to find partners from around the world so that innovations can benefit patients faster,” said Kung.
The Ministry of Health and Care Services was also represented, with Maiken Engelstad, Director General of the Department of Specialist Health Services, in attendance.
About DNV:
DNV’s health program collaborates with partners through large public-private research and innovation projects to address the needs for data sharing and infrastructure, legal and regulatory challenges, cybersecurity, and to build trust that can contribute to the clinical implementation of precision medicine, AI, and new digital technologies. Read more here.